ALTO-100

DRUG2 trials

Sponsors

Alto Neuroscience

Conditions

Bipolar Disorder I or II With a Major Depressive EpisodeMajor Depressive Disorder

Phase 2

Phase 2b Study of ALTO-100 in MDD

CompletedNCT05712187

Alto NeuroscienceMajor Depressive Disorder

Start: 2023-01-10End: 2024-10-24Updated: 2025-09-08

ALTO-100 in Bipolar Disorder With Depression (BD-D)

RecruitingNCT06656416

Alto NeuroscienceBipolar Disorder I or II With a Major Depressive Episode

Start: 2024-10-02End: 2026-10-31Target: 200Updated: 2025-07-16